Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2024)
Armata Pharmaceuticals (ARMP) posted Receivables - Other of $744000.0 for Q4 2024, down 66.47% sequentially from $2.2 million in Q3 2024, and down 77.88% YoY from $3.4 million in Q1 2024.
Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2024) Analysis & Trends
Armata Pharmaceuticals has reported Receivables - Other for 3 years, with the latest figure at $744000.0 in Q4 2024.
- Quarterly Receivables - Other fell 77.88% year-over-year to $744000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $744000.0 (down 77.88% YoY) and the FY2024 annual result came in at $744000.0, down 77.88% from the prior year.
- Receivables - Other declined to $744000.0 in Q4 2024 per ARMP's latest filing, from $2.2 million in the prior quarter.
- Over five years, Receivables - Other peaked at $8.6 million in Q2 2023 and troughed at $744000.0 in Q4 2024.
- A 3-year average of $4.1 million and a median of $2.8 million in 2023 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other sank 49.01% in 2023, then tumbled 91.34% in 2024.
- Over 3 years, Receivables - Other stood at $6.6 million in 2022, then tumbled by 49.01% to $3.4 million in 2023, then plunged by 77.88% to $744000.0 in 2024.
- According to Business Quant data, Receivables - Other over the past three periods registered $744000.0, $2.2 million, and $748000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 744,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 748,000.00 |
| Mar 31, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Sep 30, 2023 | 8.50 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Dec 31, 2022 | 6.60 Mn |